Endometrial cancer: Molecular markers and management of advanced stage disease

Gynecologic Oncology
Rebecca C ArendPaul Goodfellow

Abstract

Endometrial cancer is the most prevalent gynecologic cancer in the United States. Over the last 10 years, death rates from endometrial cancer have been rising about 1.4% per year. Traditionally endometrial cancer treatment has been driven by stage and histology. Recent studies have, however, shown that cancers of the same stage and histology have very distinct molecular and genomic profiles. Translational research is progressing rapidly and endometrial cancer-specific precision medicine is evolving. The first tissue agnostic therapy based on the molecular profile of the tumor was approved by the FDA this year. The approval of immune checkpoint inhibitor, pembrolizumab (anti-PD-1), for all solid tumors with defective DNA mismatch repair, could benefit 20-30% of patients with advanced endometrial cancer. Other genomic changes and molecular markers in endometrial cancer, such as hormone receptor status, could lead to more tailored therapy in the future. Pre-clinical and clinical investigations of targeted therapies suggest efficacy for some agents. Single agent targeted therapies, however, have modest activity. Identifying biomarkers that effectively determine response to targeted therapy remains a challenge. The next generation o...Continue Reading

Citations

May 29, 2020·Japanese Journal of Clinical Oncology·Yoichi AokiNobuhiro Takeshima
Dec 21, 2018·Current Opinion in Obstetrics & Gynecology·Matthew CowanDaniela Matei
Jul 28, 2020·International Journal of Molecular Sciences·Omid KooshkakiBehzad Baradaran
Aug 20, 2019·World Journal of Clinical Cases·Mian-Li ZhouHui Mao
Aug 14, 2019·Oncology Letters·Michelle Van SinderenEvdokia Dimitriadis
Jun 19, 2020·Cancer Cell International·Hongyu ZhouXi Cheng
Nov 18, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Xinyu WuPei Hui
Mar 21, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Robert L Coleman
Jan 27, 2019·BMC Women's Health·Shiying SunYue Zhao
Nov 14, 2019·Cancers·Pooja PanditaShannon M Hawkins
Nov 21, 2020·Archives of Gynecology and Obstetrics·Guojiao LuPeishu Liu
Jan 31, 2021·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·C KongL Chen
Feb 4, 2021·Medicine·Jie JiangXinli Zhan
Feb 1, 2021·Gynecologic Oncology·Chad A HamiltonWilliam M Burke
Feb 10, 2021·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Fan ZhangZhao-Jun Wei
Feb 20, 2021·Cancer Cell International·Fahime JahanbakhshiJamal Halajzadeh
Mar 18, 2021·American Journal of Clinical Pathology·Terrell E JonesRohit Bhargava
May 18, 2021·Indian Journal of Surgical Oncology·T S ShylasreeSeema Gulia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Related Papers

Gynecologic Oncology Research and Practice
Vicky MakkerDavid Scott Miller
Differentiation; Research in Biological Diversity
Satu KuokkanenJeffrey W Pollard
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer
Eileen ShawChristine Friedenreich
American Family Physician
T P Canavan, N R Doshi
© 2022 Meta ULC. All rights reserved